Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 20,516 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $22.61, for a total transaction of $463,866.76. Following the completion of the sale, the insider owned 2,187,791 shares of the company’s stock, valued at $49,465,954.51. This trade represents a 0.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total value of $15,404.22.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total transaction of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total transaction of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Up 0.8%

Shoulder Innovations stock opened at $22.24 on Tuesday. The firm has a market capitalization of $463.02 million and a P/E ratio of -11.58. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. Shoulder Innovations, Inc. has a twelve month low of $10.92 and a twelve month high of $24.59. The stock’s fifty day simple moving average is $21.03 and its 200-day simple moving average is $16.60.

Shoulder Innovations (NYSE:SI) last released its earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. The company had revenue of $17.18 million during the quarter. As a group, equities analysts expect that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently weighed in on SI. BTIG Research raised their target price on shares of Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, August 7th. Piper Sandler reiterated an “overweight” rating and set a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. Weiss Ratings upgraded shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, August 3rd. Finally, UBS Group lifted their price objective on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Five analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Shoulder Innovations currently has an average rating of “Moderate Buy” and an average target price of $25.50.

Institutional Investors Weigh In On Shoulder Innovations

Several institutional investors have recently added to or reduced their stakes in the business. Compass Financial Management LLC acquired a new position in Shoulder Innovations in the second quarter valued at approximately $30,000. Wells Fargo & Company MN raised its holdings in Shoulder Innovations by 66.3% during the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after purchasing an additional 2,094 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Shoulder Innovations during the third quarter worth approximately $28,000. California State Teachers Retirement System lifted its position in shares of Shoulder Innovations by 412.4% during the 2nd quarter. California State Teachers Retirement System now owns 2,941 shares of the company’s stock worth $60,000 after buying an additional 2,367 shares during the last quarter. Finally, Rhumbline Advisers acquired a new position in shares of Shoulder Innovations in the 3rd quarter valued at $54,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.